Keywords: AstraZeneca, Brilique, Reimbursement, France, Brilinta

AstraZeneca pulls French Brilique reimbursement filing

Article | 25 March 2011

Anglo-Swedish drug major AstraZeneca (LSE: AZN) said it has withdrawn a reimbursement application for its potentially blockbuster blood thinner Brilique ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in